Cardiologists treating patients with atherosclerotic cardiovascular disease are increasingly initiating semaglutide as a cardiovascular risk modifier, adding an estimated 4.8 million new commercial GLP-1 patients annually
The dark side of the spoon - glucose, ketones and COVID-19: a possible role for ketogenic diet
$100 OFF your first month
To order for others, please purchase a gift card or contact Customer Service
At Purna, we are driven by the belief that happiness comes from feeling your best on the inside, therefore, we always strive to helping you live healthier
Research has shown that 18 weeks of liraglutide intervention can possibly be related to reducing proliferation and inflammation of hypothalamic microglia in resetting the body weight set point (BWSP) of diet-induced obese (DIO) rats ( An important component of GLP-1RA treatment is lifestyle intervention, including exercise and low-calorie diet, which is crucial for weight maintenance